{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T17:02:12Z","timestamp":1753894932903,"version":"3.41.2"},"reference-count":13,"publisher":"Becaris Publishing Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.57264\/cer-2023-0082","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:45:49Z","timestamp":1685702749000},"source":"Crossref","is-referenced-by-count":1,"title":["Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome"],"prefix":"10.57264","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-1059","authenticated-orcid":false,"given":"Christina","family":"Deligianni","sequence":"first","affiliation":[{"name":"Department of Neurology, Athens Naval Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-4128","authenticated-orcid":false,"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[{"name":"Department of Clinical & Molecular Medicine, Sapienza University, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-3388","authenticated-orcid":false,"given":"Dimos D","family":"Mitsikostas","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aeginition Hospital, National & Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10194-023-01569-2","article-title":"Shared and independent roles of CGRP and PACAP in migraine pathophysiology","volume":"24","author":"Kuburas A","year":"2023","unstructured":"Kuburas A, Russo AF. Shared and independent roles of CGRP and PACAP in migraine pathophysiology. J. Headache Pain 24, 34 (2023).","journal-title":"J. Headache Pain"},{"issue":"2","key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.13582","article-title":"Targeting CGRP and 5-HT1F receptors for the acute therapy of migraine: a literature review","volume":"59","author":"Moreno-Ajona D","year":"2019","unstructured":"Moreno-Ajona D, Chan C, Villar-Mart\u00ednez MD, Goadsby PJ. Targeting CGRP and 5-HT1F receptors for the acute therapy of migraine: a literature review. Headache 59(S2), 3\u201319 (2019).","journal-title":"Headache"},{"issue":"7","key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/14656566.2020.1862793","article-title":"Novel synthetic treatment options for migraine","volume":"22","author":"Negro A","year":"2021","unstructured":"Negro A, Martelletti P. Novel synthetic treatment options for migraine. Expert Opin. Pharmacother. 22(7), 907\u2013922 (2021).","journal-title":"Expert Opin. Pharmacother."},{"issue":"6","key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13543784.2019.1618830","article-title":"Gepants for the treatment of migraine","volume":"28","author":"Negro A","year":"2019","unstructured":"Negro A, Martelletti P. Gepants for the treatment of migraine. Expert Opin. Investig. Drugs 28(6), 555\u2013567 (2019).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.msard.2017.08.003","article-title":"Comparing the efficacy of disease-modifying therapies in multiple sclerosis","volume":"18","author":"Mitsikostas DD","year":"2017","unstructured":"Mitsikostas DD, Goodin DS. Comparing the efficacy of disease-modifying therapies in multiple sclerosis. Mult. Scler. Relat. Disord. 18, 109\u2013116 (2017).","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s10194-020-01178-3","article-title":"European Headache Federation recommendations for placebo and nocebo terminology","volume":"21","author":"Mitsikostas DD","year":"2020","unstructured":"Mitsikostas DD, Blease C, Carlino E European Headache Federation recommendations for placebo and nocebo terminology. J. Headache Pain 21(1), 117 (2020).","journal-title":"J. Headache Pain"},{"issue":"7","key":"e_1_3_3_8_2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/0333102421989601","article-title":"Anti-CGRP monoclonal antibodies for migraine prevention: a systematic review and likelihood to help or harm analysis","volume":"41","author":"Drellia K","year":"2021","unstructured":"Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, Mitsikostas DD. Anti-CGRP monoclonal antibodies for migraine prevention: a systematic review and likelihood to help or harm analysis. Cephalalgia 41(7), 851\u2013864 (2021).","journal-title":"Cephalalgia"},{"issue":"3","key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/j.pain.0000000000002365","article-title":"Different routes of administration in chronic migraine prevention lead to different placebo responses: a meta-analysis","volume":"163","author":"Swerts DiB","year":"2022","unstructured":"Swerts DiB, Benedetti F, Peres MFP. Different routes of administration in chronic migraine prevention lead to different placebo responses: a meta-analysis. Pain 163(3), 415\u2013424 (2022).","journal-title":"Pain"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/bs.irn.2018.07.025","article-title":"Nocebo responses in brain diseases: a systematic review of the current literature","volume":"139","author":"Zis P","year":"2018","unstructured":"Zis P, Mitsikostas DD. Nocebo responses in brain diseases: a systematic review of the current literature. Int. Rev. Neurobiol. 139, 443\u2013462 (2018).","journal-title":"Int. Rev. Neurobiol."},{"issue":"5","key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0333102410391485","article-title":"Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches","volume":"31","author":"Mitsikostas DD","year":"2011","unstructured":"Mitsikostas DD, Mantonakis LI, Chalarakis NG. Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia 31(5), 550\u2013561 (2011).","journal-title":"Cephalalgia"},{"issue":"4","key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00415-019-09673-7","article-title":"Placebo and nocebo phenomena in anti-CGRP monoclonal antibody trials for migraine prevention: a meta-analysis","volume":"267","author":"Kokoti L","year":"2020","unstructured":"Kokoti L, Drellia K, Papadopoulos D, Mitsikostas DD. Placebo and nocebo phenomena in anti-CGRP monoclonal antibody trials for migraine prevention: a meta-analysis. J. Neurol. 267(4), 1158\u20131170 (2020).","journal-title":"J. Neurol."},{"key":"e_1_3_3_13_2","article-title":"Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration","author":"Fawsitt CG","year":"2023","unstructured":"Fawsitt CG, Thom H, Regnier SA, Lee XY, Kymes S, Vase L. Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration. J. Comp. Eff. Res. (2023). (Online ahead of print)","journal-title":"J. Comp. Eff. Res."},{"issue":"8","key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/head.13907","article-title":"Efficacy and contextual (placebo) effects of CGRP antibodies for migraine: systematic review and meta-analysis","volume":"60","author":"Forbes RB","year":"2020","unstructured":"Forbes RB, McCarron M, Cardwell CR. Efficacy and contextual (placebo) effects of CGRP antibodies for migraine: systematic review and meta-analysis. Headache 60(8), 1542\u20131557 (2020).","journal-title":"Headache"}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2023-0082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:28:49Z","timestamp":1688124529000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2023-0082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.57264\/cer-2023-0082"],"URL":"https:\/\/doi.org\/10.57264\/cer-2023-0082","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"type":"print","value":"2042-6305"},{"type":"electronic","value":"2042-6313"}],"subject":[],"published":{"date-parts":[[2023,7]]},"article-number":"e230082"}}